Literature DB >> 21854420

Postvaccination morphea profunda in a child.

Aida Khaled1, Monia Kharfi, Anissa Zaouek, Soumaya Rameh, Rachida Zermani, Becima Fazaa, Mohamed Ridha Kamoun.   

Abstract

We report a new case of postvaccination morphea profunda (MP) in a child and discuss its different clinical presentations, prognosis, and therapy and its relationship with "solitary morphea profunda." A 2-year-old healthy girl presented with an induration of the anterior aspect of the left thigh of 9 months duration. The lesion had appeared 3 months after a third dose of diphtheria-tetanus-pertussis vaccine. Cutaneous examination showed an induration of 7 × 7 cm with an "orange peel" texture after pinching the skin. Histologic examination confirmed the diagnosis of MP. Systemic steroids (1 mg/kg/day) led to the stabilization of the lesion. After 4 months of treatment, we began the concomitant use of oral methotrexate (10 mg/wk) for 2 months. Methotrexate was then continued alone for 10 months, leading to a significant regression of the induration with no relapse.
© 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21854420     DOI: 10.1111/j.1525-1470.2011.01548.x

Source DB:  PubMed          Journal:  Pediatr Dermatol        ISSN: 0736-8046            Impact factor:   1.588


  5 in total

Review 1.  Vaccinations in juvenile chronic inflammatory diseases: an update.

Authors:  Clovis A Silva; Nadia E Aikawa; Eloisa Bonfa
Journal:  Nat Rev Rheumatol       Date:  2013-07-02       Impact factor: 20.543

Review 2.  The Immunogenetics of Morphea and Lichen Sclerosus.

Authors:  Pooya Khan Mohammad Beigi
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

Review 3.  Current Take on Systemic Sclerosis Patients' Vaccination Recommendations.

Authors:  Giuseppe Murdaca; Giovanni Noberasco; Dario Olobardi; Claudio Lunardi; Matteo Maule; Lorenzo Delfino; Massimo Triggiani; Chiara Cardamone; Devis Benfaremo; Gianluca Moroncini; Angelo Vacca; Nicola Susca; Sebastiano Gangemi; Paola Quattrocchi; Laura Sticchi; Giancarlo Icardi; Andrea Orsi
Journal:  Vaccines (Basel)       Date:  2021-12-02

4.  A case of generalized morphea profunda following SARS-CoV-2 infection.

Authors:  Michael R Stephens; Duncan F Moore; Jonathan Dau; Soma Jobbagy; Victor A Neel; Marcy B Bolster; Flavia Fedeles
Journal:  JAAD Case Rep       Date:  2022-03-12

Review 5.  Generalized morphea following the COVID vaccine: A series of two patients and a bibliographic review.

Authors:  Javier Antoñanzas; Nuria Rodríguez-Garijo; Ángela Estenaga; Ana Morelló-Vicente; Agustín España; Leyre Aguado
Journal:  Dermatol Ther       Date:  2022-07-20       Impact factor: 3.858

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.